Summit Therapeutics schedules Q2 2023 earnings call for August 9

Summit Therapeutics Inc.

2023-Q2 EPS reported -$1.03

Press release announces Q2 2023 financial results and operational update call on August 9, 2023 before market open.
Call will be webcast at 9:00am ET via Summit's website; no financial data disclosed in this filing.
No preliminary earnings, guidance, or operational metrics provided—only call scheduling.
Ticker SMMT; company headquartered in Menlo Park, CA.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.4

Summit Therapeutics Inc. reported financial results for second quarter 2023.

Period: second quarter 2023
Result: reported results

Exact text from the filing

On August 2, 2023, Summit Therapeutics Inc. (“Summit” or the “Company”) issued a press release announcing that the Company will host an earnings call to announce its second quarter 2023 financial results and provide an operational update for the Company on Wednesday, August 9, 2023, at 9:00am ET, before the market opens.

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

Summit Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0001599298-23-000069

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.